Material Event (Form 8-K)

Item 8.01 Other Events.

On April 19, 2025, the Board of Directors (the "Board") of Cyclacel Pharmaceuticals, Inc. (the "Company") declared a quarterly cash dividend of $0.15 per share on the Company's 6% Convertible Exchangeable Preferred Stock (the "Preferred Stock"). The cash dividend will be payable on May 1, 2025, to Preferred Stock stockholders of record as of the close of business on April 29, 2025.

The Board considered numerous factors in determining whether to declare the quarterly dividend, including the requisite financial analysis and determination of a surplus. While the Board will analyze the advisability of the declaration of dividends in future quarters, there is no assurance that future quarterly dividends will be declared